The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma
Background. Esophageal squamous cell carcinoma was treated by operation and chemoradiotherapy. However, the prognosis of most patients is poor after treatment, and most studies have shown that FGF2 and its receptor (FGFR) are involved in the development of various malignant tumors. FGF2 plays an imp...
Saved in:
| Main Authors: | Wenjing Zhang, Yaxing Zhou, Chao Li, Shanshan Xu, Mengyan Li, Wenying Liu, Yuqing Ma, Hui Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2020/2872479 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alterations in HMGB1, ROS1, FGFR1, FGFR2, IL6, and TLR4 are associated with worse survival in patients with esophageal squamous cell carcinoma
by: Victor C. Kok, et al.
Published: (2025-03-01) -
Glucocorticoids trigger muscle-liver crosstalk to attenuate acute liver injury and promote liver regeneration via the FGF6-FGFBP1 axis
by: Yue-Jie Xu, et al.
Published: (2025-07-01) -
Bulk and single-cell RNA sequencing identify prognostic signatures related to FGFBP2+ NK cell in hepatocellular carcinoma
by: Yinbing Wu, et al.
Published: (2025-05-01) -
Prognostic value of immunosuppression scores in patients with esophageal squamous cell carcinoma: a multicenter study
by: Shao-jun Xu, et al.
Published: (2025-01-01) -
Decoding FGF/FGFR Signaling: Insights into Biological Functions and Disease Relevance
by: Oshadi Edirisinghe, et al.
Published: (2024-12-01)